Consensus West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Market Closed - Nyse Other stock markets 04:00:02 2024-04-18 pm EDT			5-day change	1st Jan Change
377.3 ^USD	-0.01%		-2.64%	+7.16%

Mar. 29	Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	RE
Mar. 19	Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM

Evolution of the average Target Price on West Pharmaceutical Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5c4d5.BPpUU4g-jbXIHBfaSvA1-qIzqlFT6_MXRt0kcHDqMhc.Kc0iIcl47vOOdi6FeKBZuNB79SAm2oBVNadlEgiOfXBQzxJmuAne4r1XdA~184b96accc3afbda6c0f6a2ecfd68ea7

Analyst Recommendations on West Pharmaceutical Services, Inc.

UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	Feb. 16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	Feb. 16	MT
Forget about rate cuts...	Feb. 16
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
Wall Street ends higher as retail sales slump feeds hopes for rate cuts	Feb. 15	RE
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	Feb. 13	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Joe Biden and Xi Jinping almost made up	Nov. 16
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	Nov. 16
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	23-10-27	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	23-10-27	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	23-08-30	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	23-08-21	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	23-07-20	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	23-07-17	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	23-07-10	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	23-06-16	MT
UBS Adjusts West Pharmaceutical Services Price Target to $365 From $356, Maintains Neutral Rating	23-04-28	MT
Stephens Upgrades West Pharmaceutical Services to Overweight From Equalweight, Raises Price Target to $400 From $330	23-04-11	MT
UBS Raises Price Target on West Pharmaceutical Services to $356 From $324, Keeps Neutral Rating	23-04-10	MT
UBS Adjusts West Pharmaceutical Services Price Target to $324 From $250, Maintains Neutral Rating	23-02-24	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $290 From $250, Maintains Hold Rating	23-02-22	MT
Morningstar Downgrades West Pharmaceutical Services to Sell From Hold With $280 Price Target	23-02-17	MT